ROKTRUIS Trademark

Trademark Overview

On Tuesday, January 21, 2020, a trademark application was filed for ROKTRUIS with the United States Patent and Trademark Office. The USPTO has given the ROKTRUIS trademark a serial number of 88767898. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 17, 2023. This trademark is owned by Biomarin Pharmaceutical Inc.. The ROKTRUIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of genetic diseases and disorders
roktruis

General Information

Serial Number88767898
Word MarkROKTRUIS
Filing DateTuesday, January 21, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 17, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 21, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of genetic diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, January 25, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBiomarin Pharmaceutical Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNovato, CA 94949
Party NameBiomarin Pharmaceutical Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNovato, CA 94949

Trademark Events

Event DateEvent Description
Monday, July 17, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 17, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, November 29, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 28, 2022SOU EXTENSION 5 GRANTED
Monday, November 14, 2022SOU EXTENSION 5 FILED
Monday, November 28, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 14, 2022TEAS EXTENSION RECEIVED
Saturday, June 18, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 16, 2022SOU EXTENSION 4 GRANTED
Thursday, June 16, 2022SOU EXTENSION 4 FILED
Thursday, June 16, 2022TEAS EXTENSION RECEIVED
Thursday, December 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 14, 2021SOU EXTENSION 3 GRANTED
Tuesday, December 14, 2021SOU EXTENSION 3 FILED
Tuesday, December 14, 2021TEAS EXTENSION RECEIVED
Wednesday, June 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 14, 2021SOU EXTENSION 2 GRANTED
Monday, June 14, 2021SOU EXTENSION 2 FILED
Monday, June 14, 2021TEAS EXTENSION RECEIVED
Saturday, November 7, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 5, 2020SOU EXTENSION 1 GRANTED
Thursday, November 5, 2020SOU EXTENSION 1 FILED
Thursday, November 5, 2020TEAS EXTENSION RECEIVED
Tuesday, June 16, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 21, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 21, 2020PUBLISHED FOR OPPOSITION
Wednesday, April 1, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 16, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 13, 2020ASSIGNED TO EXAMINER
Saturday, January 25, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, January 24, 2020NEW APPLICATION ENTERED

Related Keywords

roktruis diseases disorders genetic treatment preparations pharmaceutical